The Toxicity and Preliminary Clinical Outcomes of Low-Dose Weekly Cisplatin-Based Concurrent Chemoradiotherapy |
Kim, Tae-Yong
(Department of Internal Medicine, Seoul National University Boramae Hospital)
Kim, Kyoung-Ju (Department of Radiation Oncology, Hallym University Kangnam Sacred Heart Hospital) Kim, Ki-Hwan (Department of Internal Medicine, Seoul National University Boramae Hospital) Kim, Ji-Eun (Department of Pathology, Seoul National University Boramae Hospital) Park, Sun-Won (Department of Radiology, Seoul National University Boramae Hospital) Oh, So-Won (Department of Nuclear Medicine, Seoul National University Boramae Hospital) Jung, Young-Ho (Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Boramae Hospital) |
1 | Geeta SN, Padmanabhan TK, Samuel J, Pavithran K, Iyer S, Kuriakose MA. Comparison of acute toxicities of two chemotherapy schedules for head and neck cancers. J Cancer Res Ther. 2006;2(3):100-104. DOI ScienceOn |
2 | Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis. J Clin Oncol. 2008;26(21):3582-3589. DOI ScienceOn |
3 | Chan AT, Teo PM, Ngan RK, Leung TW, Lau WH, Zee B, et al. Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: Progression-free survival analysis of a phase III randomized trial. J Clin Oncol. 2002;20(8):2038-2044. DOI ScienceOn |
4 | Maguire PD, Papagikos M, Hamann S, Neal C, Meyerson M, Hayes N, et al. Phase II trial of hyperfractionated intensity-modulated radiation therapy and concurrent weekly cisplatin for Stage III and IVa head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2011;79(4):1081-1088. DOI ScienceOn |
5 | Loimu V, Collan J, Vaalavirta L, Back L, Kapanen M, Makitie A, et al. Patterns of relapse following definitive treatment of head and neck squamous cell cancer by intensity modulated radiotherapy and weekly cisplatin. Radiother Oncol. 2011;98(1):34-37. DOI ScienceOn |
6 | Watkins JM, Zauls AJ, Wahlquist AH, Shirai K, Garrett-Mayer E, Gillespie MB, et al. Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer. Laryngoscope. 2010;120(2):236-242. DOI |
7 | Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349(22):2091-2098. DOI ScienceOn |
8 | Adelstein DJ, Li Y, Adams GL, Wagner H Jr, Kish JA, Ensley JF, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003;21(1):92-98. DOI ScienceOn |
9 | Steinmann D, Cerny B, Karstens JH, Bremer M. Chemoradiotherapy with weekly cisplatin 40mg/m(2) in 103 head-and-neck cancer patients: a cumulative dose-effect analysis. Strahlenther Onkol. 2009;185(10):682-688. DOI ScienceOn |
10 | Beckmann GK, Hoppe F, Pfreundner L, Flentje MP. Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer. Head Neck. 2005;27(1):36-43. DOI ScienceOn |
11 | NCCN clinical practice guideline in Oncology, head and neck cancers. Available from: URL: http://www.nccn.org/professionals/physician_gls/PDF/head-and-neck.pdf. |
12 | Tsang RY, Al-Fayea T, Au HJ. Cisplatin overdose: toxicities and management. Drug Saf. 2009;32(12):1109-1122. DOI ScienceOn |
13 | Pignon JP, le Maitre A, Maillard E, Bourhis J. Meta-analysis of chemotherapy in head and neck cancer(MACH-NC): An update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009;92(1):4-14. DOI ScienceOn |
14 | Quon H, Leong T, Haselow R, Leipzig B, Cooper J, Forastiere A. Phase III Study of Radiation Therapy With or Without Cis- Platinum in Patients with Unresectable Squamous or Undifferentiated Carcinoma of the Head and Neck: An Intergroup Trial of the Eastern Cooperative Oncology Group(E2382). Int J Radiat Oncol Biol Phys. In press;2010. |
15 | 국가암등록사업 연례보고서. Available from: URL: http://www.ncc.re.kr/manage/manage03_033_view.jsp?bbsnum=150&hSelSearch=&hTxtKeyword=¤t_ page=1&cd=null |
16 | Marur S, Forastiere AA. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2008;83(4):489-501. DOI ScienceOn |
17 | Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin. 2002;52(1):23-47. DOI ScienceOn |